InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Amortization of Deferred Charges (2016 - 2018)

InflaRx's (IFRX) quarterly Amortization of Deferred Charges came in at $515266.2 in Q3 2018, down 48.35% year-over-year from $997628.7 in Q3 2017, and up 631.77% quarter-over-quarter from $70413.2 in Q2 2018.

Analysis

InflaRx (IFRX) Amortization of Deferred Charges (2016 - 2018) Analysis & Trends

InflaRx has disclosed Amortization of Deferred Charges across 3 years of filings, most recently posting $515266.2 for Q3 2018.

  • In Q3 2018, Amortization of Deferred Charges fell 48.35% year-over-year to $515266.2; the TTM figure through Sep 2018 stood at $6.1 million (up 64.31% YoY), while the FY2017 annual figure was $5.6 million, up 145.1% from the prior year.
  • Amortization of Deferred Charges came in at $515266.2 for Q3 2018 at InflaRx, up from $70413.2 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $2.8 million in Q4 2017 to a low of $70413.2 in Q2 2018.
  • Average Amortization of Deferred Charges over 3 years is $1.2 million, with a median of $930970.7 recorded in 2016.
  • The largest YoY upside for Amortization of Deferred Charges was 210.33% in 2018 against a maximum downside of 92.39% in 2018.
  • Over 3 years, Amortization of Deferred Charges stood at $936120.9 in 2016, then surged by 204.26% to $2.8 million in 2017, then sank by 81.91% to $515266.2 in 2018.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $515266.2 in Q3 2018, $70413.2 in Q2 2018, and $2.7 million in Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 515,266.22
Jun 30, 2018 70,413.22
Mar 31, 2018 2.69 Mn
Dec 31, 2017 2.85 Mn
Sep 30, 2017 997,628.71
Jun 30, 2017 925,820.53
Mar 31, 2017 866,175.81
Dec 31, 2016 936,120.90